GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer GalleriĀ® Multi-Cancer Early Detection Blood Test

Author's Avatar
Dec 06, 2021

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, announced today a partnership with Alignment Health Plan, a national Medicare Advantage health plan from Alignment+Healthcare (NASDAQ: ALHC), to provide its Medicare Advantage members access to GalleriĀ®, GRAILā€™s groundbreaking multi-cancer early detection blood test. Based in Orange, California, Alignment Health Plan is the first Medicare Advantage plan to offer the Galleri test as a complement to recommended single cancer screenings.